Annexin and survivin in locally advanced rectal cancer: Indicators of resistance to preoperative chemoradiotherapy?

Onkologie

Volumn 33, Issue 8-9, 2010, Pages 439-444

  Horisberger, Karoline ^a   Erben, Philipp ^a   Ströbel, Philipp ^b   Bohn, Beatrice ^a   Hahn, Melanie ^a   Kähler, Georg ^a   Wenz, Frederik ^a   Hochhaus, Andreas ^a,c   Post, Stefan ^a   Willeke, Frank ^d   Hofheinz, Ralf Dieter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c JENA UNIVERSITY HOSPITAL   (Germany)

^d Chirurgische Klinik   (Germany)

Author keywords

Annexin; Apoptosis; Chemoradiotherapy; Rectal cancer; Survivin

Indexed keywords

ANNEXIN; ANTINEOPLASTIC AGENT; CAPECITABINE; CETUXIMAB; IRINOTECAN; LIPOCORTIN 4; LIPOCORTIN 5; MESSENGER RNA; SURVIVIN;

ADJUVANT THERAPY; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RESISTANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOCALLY ADVANCED RECTAL CANCER; MULTIMODALITY CANCER THERAPY; PREOPERATIVE PERIOD; PREOPERATIVE RADIOTHERAPY; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIOCHEMOTHERAPY; REAL TIME POLYMERASE CHAIN REACTION; RECTUM; RECTUM BIOPSY; RECTUM CANCER; RECTUM MUCOSA; RECTUM SURGERY; RISK FACTOR; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANNEXINS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; PREOPERATIVE CARE; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 77956622841     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000318145     Document Type: Article

References (30)

1. Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-1740.
2. Rodel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C: Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-8696.
3. Janjan NA, Crane C, Feig BW, Cleary K, Dubrow R, Curley S, Vauthey JN, Lynch P, Ellis LM, Wolff R, Lenzi R, Abbruzzese J, Pazdur R, Hoff PM, Allen P, Brown T, Skibber J: Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 2001;24:107-112.
4. Mohiuddin M, Hayne M, Regine WF, Hanna N, Hagihara PF, McGrath P, Marks GM: Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced/ recurrent rectal cancers. Int J Radiat Oncol Biol Phys 2000;48:1075-1080.
5. Capirci C, Valentini V, Cionini L, De Paoli A, Rodel C, Glynne-Jones R, Coco C, Romano M, Mantello G, Palazzi S, Mattia FO, Friso ML, Genovesi D, Vidali C, Gambacorta MA, Buffoli A, Lupattelli M, Favretto MS, La Torre G: Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008;72:99-107.
6. Meyn RE, Stephens LC, Ang KK, Hunter NR, Brock WA, Milas L, Peters LJ: Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies. Int J Radiat Biol 1993;64:583-591. (Pubitemid 23350460)
7. Meyn RE, Stephens LC, Milas L: Programmed cell death and radioresistance. Cancer Metastasis Rev 1996;15:119-131.
8. Ambrosini G, Adida C, Altieri DC: A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997;3:917-921.
9. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 1998;17:3247-3259.
10. Li F, Brattain MG: Role of the survivin gene in pathophysiology. Am J Pathol 2006;169:1-11.
11. Rodel C, Haas J, Groth A, Grabenbauer GG, Sauer R, Rodel F: Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: Survivin as a radioresistance factor. Int J Radiat Oncol Biol Phys 2003;55:1341-1347.
12. Rodel F, Hoffmann J, Grabenbauer GG, Papadopoulos T, Weiss C, Gunther K, Schick C, Sauer R, Rodel C: High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiochemotherapy and surgical resection. Strahlenther Onkol 2002;178:426-435.
13. Gerke V, Moss SE: Annexins: From structure to function. Physiol Rev 2002;82:331-371.
14. Gerke V, Moss SE: Annexins and membrane dynamics. Biochim Biophys Acta 1997;1357:129-154.
15. Dreier R, Schmid KW, Gerke V, Riehemann K: Differential expression of annexins I, II and IV in human tissues: An immunohistochemical study. Histochem Cell Biol 1998;110:137-148.
16. Han EK, Tahir SK, Cherian SP, Collins N, Ng SC: Modulation of paclitaxel resistance by annexin IV in human cancer cell lines. Br J Cancer 2000;83:83-88.
17. Corsten MF, Hofstra L, Narula J, Reutelingsperger CP: Counting heads in the war against cancer: Defining the role of annexin A5 imaging in cancer treatment and surveillance. Cancer Res 2006;66:1255-1260.
18. Hofheinz RD, Horisberger K, Woernle C, Wenz F, Kraus-Tiefenbacher U, Kahler G, Dinter D, Grobholz R, Heeger S, Post S, Hochhaus A, Willeke F: Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer. Int J Radiat Oncol Biol Phys 2006;66:1384-1390.
19. Horisberger K, Treschl A, Mai S, Barreto-Miranda M, Kienle P, Strobel P, Erben P, Woernle C, Dinter D, Kahler G, Hochhaus A, Post S, Willeke F, Wenz F, Hofheinz RD: Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: Results of a phase II MARGIT trial. Int J Radiat Oncol Biol Phys 2009;74:1487-1493.
20. Muller MC, Erben P, Saglio G, Gottardi E, Nyvold CG, Schenk T, Ernst T, Lauber S, Kruth J, Hehlmann R, Hochhaus A: Harmonization of bcr-abl mRNA quantification using a uniform multifunctional control plasmid in 37 international laboratories. Leukemia 2008;22:96-102.
21. Kim KW, Mutter RW, Willey CD, Subhawong TK, Shinohara ET, Albert JM, Ling G, Cao C, Gi YJ, Lu B: Inhibition of survivin and aurora B kinase sensitizes mesothelioma cells by enhancing mitotic arrests. Int J Radiat Oncol Biol Phys 2007;67:1519-1525.
22. Ma X, Wang S, Zhou J, Xing H, Xu G, Wang B, Chen G, Lu YP, Ma D: Induction of apoptosis in human ovarian epithelial cancer cells by antisurvivin oligonucleotides. Oncol Rep 2005;14:275-279.
23. Cao C, Mu Y, Hallahan DE, Lu B: XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer. Oncogene 2004;23:7047-7052. (Pubitemid 39319166)
24. Sharma H, Sen S, Lo Muzio L, Mariggio A, Singh N: Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy. Cancer Biol Ther 2005;4:720-727.
25. Terzi C, Canda AE, Sagol O, Atila K, Sonmez D, Fuzun M, Gorken IB, Oztop I, Obuz F: Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy. Int J Colorectal Dis 2008;23:37-45.
26. Didelot C, Mirjolet JF, Barberi-Heyob M, Ramacci C, Merlin JL: Radiation could induce p53-independent and cell cycle-unrelated apoptosis in 5-fluorouracil radiosensitized head and neck carcinoma cells. Can J Physiol Pharmacol 2002;80:638-643.
27. Allal AS, Kahne T, Reverdin AK, Lippert H, Schlegel W, Reymond MA: Radioresistance-related proteins in rectal cancer. Proteomics 2004;4:2261-2269.
28. Shi T, Dong F, Liou LS, Duan ZH, Novick AC, DiDonato JA: Differential protein profiling in renal-cell carcinoma. Mol Carcinog 2004;40:47-61.
29. Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA: Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 2003;162:255-261.
30. McDonnell CO, Bouchier-Hayes DJ, Toomey D, Foley D, Kay EW, Leen E, Walsh TN: Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer. Br J Surg 2003;90:1373-1378.